About GluSense
GluSense is a company based in Lod (Israel) founded in 2007. It operates as a B2B. GluSense has raised $26.9 million across 2 funding rounds from investors including ZTE, T1D Fund and Ping An Ventures. GluSense operates in a competitive market with competitors including Dexcom, Livongo, One Drop, mySugr and Senseonics, among others.
- Headquarter Lod, Israel
- SectorsHealthcare
- Website glusensemedical.com
- Legal Name Glusense Ltd (Israel Company)
- Total Equity Funding$26.9M (USD)
in 2 rounds
- Latest Funding Round$1.9M (USD), Series A
Feb 2017
- InvestorsZTE
& 3 more
Funding Insights of GluSense
GluSense has successfully raised a total of $26.9M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $1.9 million completed in February 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $26.9M
- Total Rounds 2
- Last Round Series A — $1.9M
- First Round $25M
(Feb 2015)
- Investors Count 4
All 2 funding rounds of GluSense with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2017 | $1.9M | Series A | – | T1D Fund | – |
| Feb 2015 | $25M | Series A | – | Ping An Ventures, Yongjin Group | – |
4 investors in total: 4 institutional.
Investors in GluSense
GluSense has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include ZTE, T1D Fund and Ping An Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Companies developing T1D products are funded through venture philanthropy. | – | t1dfund.org | Boston, United States | |
Corporate-backed venture capital firm focused on retail tech, mobile tech, and multiple sectors | – | pinganventures.com | Pudong, China | |
- | – | yongjin.com.cn | - | |
Enterprise SD WAN network management solutions are provided globally. | 1985 | zte.com.cn | Shenzhen, China |
Investor details for GluSense
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of GluSense
3 dated milestones of GluSense across 10 years, from founding to its latest funding, stage changes and deals.
- Founded GluSense is founded.
- Funding First funding round of $25.0M.
- Funding Latest funding round, Series A, of $1.9M.
Competitors of GluSense
GluSense operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Dexcom, Livongo, One Drop, mySugr and Senseonics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| dexcom.com | 1999 | San Diego, United States | $52.5M | 9,600 | Wearable glucose monitoring patches are provided for real-time data tracking. | |
| livongo.com | 2014 | San Francisco, United States | $245.2M | 3,263 | Provider of smart devices for diabetes management for patients and doctors | |
| onedrop.today | 2015 | New York, United States | $107.87M | 166 | Provider of workforce healthcare solutions | |
| mysugr.com | 2012 | Vienna, Austria | $4.8M | – | Gamified apps for diabetes management and therapy are provided. | |
| senseonics.com | 1996 | Germantown, United States | $175.46M | 132 | Implantable continuous glucose monitoring systems are provided for diabetes management. | |
| janacare.com | 2011 | Newton, United States | $26.59M | – | Mobile-based diagnostics for diabetes prevention and management are provided. | |
| telcare.com | 2008 | Bethesda, United States | $66.69M | 21 | Diabetes is managed via cellular technology and social networking. | |
| caura.com | 2016 | London, United Kingdom | $4.2M | 11 | Auto insurance and vehicle services are provided via mobile app. | |
| companionmedical.com | 2013 | San Diego, United States | $24.09M | – | Smart insulin pens with Bluetooth smartphone connectivity are developed. | |
| orpyx.com | 2010 | Calgary, Canada | $25.61M | – | Wearable sensor insoles are developed for neuropathy and athletic monitoring. |
Detailed competitors of GluSense
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Glusense
Complete news archive for GluSense
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to GluSense
10 companies that operate in the same segment as GluSense (Diabetes), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of devices for continuous glucose monitoring and manual insulin delivery | 2008 | San Diego, California, United States | USD 100.73 M | USD 1.02 B | 2,650 | |
Wearable glucose monitoring patches are provided for real-time data tracking. | 1999 | San Diego, California, United States | USD 52.5 M | USD 4.66 B | 10,300 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Small molecule drugs for various therapeutic areas are developed. | 1995 | United States | USD 165 M | USD 49.8 M | 103 | |
Implantable continuous glucose monitoring systems are provided for diabetes management. | 1996 | Germantown, United States | USD 175.46 M | USD 22.47 M | 117 | |
Developer of a closed-loop automated insulin delivery system | 2014 | Milpitas, California, United States | USD 214.51 M | – | 133 | |
Provider of workforce healthcare solutions | 2015 | New York, New York, United States | USD 107.87 M | – | 166 | |
Diabetes care and reversal programs are provided to patients. | 2021 | Bengaluru, Karnataka, India | USD 26.7 M | USD 5.07 M | 677 | |
Provider of smart devices for diabetes management for patients and doctors | 2014 | San Francisco, California, United States | USD 245.2 M | – | – | |
Genetically engineered cell therapies are developed for multiple disorders. | 2018 | Seattle, Washington, United States | USD 821 M | – | 194 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about GluSense
GluSense was founded in 2007 and raised its 1st funding round 8 years after it was founded.
GluSense is headquartered in Lod, Israel. It is registered at Lod, Central District, Israel.
GluSense is a funded company, having raised a total of $26.9M across 2 funding rounds to date. The company's 1st funding round was a Series A of $25M, raised on Feb 2015.
GluSense, established in 2007, excels in providing healthcare solutions, developing medical devices, diabetes management, and glucose monitoring. Develops implantable sensors for monitoring glucose levels in type 1 diabetes patients. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
GluSense's top competitors include Dexcom, Senseonics and One Drop.
GluSense has 4 investors. Key investors include ZTE, T1D Fund, Ping An Ventures, and Yongjin Group.
GluSense operates through Glusense Ltd (Israel Company).